ALX Oncology hires Genentech, Mirati vet as CMO; After Carmot, Heather Turner has three new roles on tap

ALX Oncology has found a new chief medical officer, tapping Alan Sandler for the role.

Sandler comes to ALX from Mirati, where he was CMO …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Study reveals heart failure insights at single-cell level

Researchers examined the cell-intrinsic effects of hematopoietic stem cells with somatic mutations in circulating cells from heart failure patients.

September 6, 2023

Addressing HPV vaccination disparities in girls with mental health conditions

Girls with mental illness or neurodevelopmental conditions are less likely than their peers to be vaccinated with the HPV vaccine that protects against future cervical

August 29, 2024

Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone) – Biotech Investments

Biophytis / Key word(s): Miscellaneous Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone) 08-Apr-2024 / 23:00 CET/CEST Biophytis launches OBA phase

April 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.